Overview
Introduction
Epidemiology
Clinical Presentation
Radiology
Pathology
Staging, Prognosis, Treatment
IntroductionIdentified in 1921 by James Ewing
Differed from osteogenic sarcoma
Different location
Poor survival: 5-10% at 5 years
EpidemiologyIncidence is 0.6 per million
Males > Females
65% in the 2nd decade of life
Rare in blacks and Asians
Clinical Presentation
History:
Pain most commonly (90%)
Swelling (70%)
Fever (20%)
Pathological fracture
Weight loss, malaise
Clinical PresentationPhysical Exam and Labs
Local warmth, inflammation
Pleural effusions
Neurological signs if spinal involvement
ESR, LDH, anemia, leukocytosis
PathologyGross: soft, tan, gray tissue
Micro: nests of small round cells
No osteoid or chondroid production
Surface cell glycoprotein
Staging and PrognosisLocal and distal staging
Bone marrow aspirate
Pre-chemotherapy investigations
Biopsy
TreatmentMultidisciplinary approach
Neoadjuvant chemotherapy, surgery
Don’t prolong interval between chemo
Radiation if indicated
Top Related